keyword
https://read.qxmd.com/read/38638426/a-novel-dual-mechanism-of-action-bispecific-pd-1-il-2v-armed-by-a-%C3%AE-%C3%AE-only-interleukin-2-variant
#1
JOURNAL ARTICLE
Yongji Jiang, Chuyuan Chen, Yuan Liu, Rong Wang, Chuan Feng, Lili Cai, Shuang Chang, Lei Zhao
INTRODUCTION: Interleukin-2 (IL-2) is one of the first cytokines to be discovered as an immune agonist for cancer immunotherapy. Biased IL-2 variants had been discovered to eliminate Treg activation or enhance the tumor specific T cell cytotoxicity. However, all the biased IL-2 variants pose the risk to overstimulate immune response at a low-dose range. Here, we introduce a novel dual-MOA bispecific PD-1-IL-2v molecule with great anti-tumor efficacy in a high dosed manner. METHODS: The novel IL-2 variant was designed by structural truncation and shuffling...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38624013/integrated-high-performance-microfluidic-organic-analysis-instrument-for-planetary-and-space-exploration
#2
JOURNAL ARTICLE
Anna L Butterworth, Matin Golozar, Zachary Estlack, Jeremy McCauley, Richard A Mathies, Jungkyu Kim
The exploration of our solar system to characterize the molecular organic inventory will enable the identification of potentially habitable regions and initiate the search for biosignatures of extraterrestrial life. However, it is challenging to perform the required high-resolution, high-sensitivity chemical analyses in space and in planetary environments. To address this challenge, we have developed a microfluidic organic analyzer (MOA) instrument that consists of a multilayer programmable microfluidic analyzer (PMA) for fluidic processing at the microliter scale coupled with a microfabricated glass capillary electrophoresis (CE) wafer for separation and analysis of the sample components...
April 16, 2024: Lab on a Chip
https://read.qxmd.com/read/38622678/inequity-in-access-to-digital-public-primary-healthcare-in-sweden-a-cross-sectional-study-of-the-effects-of-urbanicity-and-socioeconomic-status-on-utilization
#3
JOURNAL ARTICLE
Jon Eriksson, Susanna Calling, Ulf Jakobsson, Moa Wolff, Beata Borgström Bolmsjö, Veronica Milos Nymberg
BACKGROUND: Social and geographical inequity in access to primary healthcare is an ongoing concern in Sweden. Digital care can potentially decrease geographical inequity. This study aimed to evaluate how urbanicity affects the utilization of a public digital primary healthcare service - PHC Online. METHODS: We performed an ecological cross-sectional study of 4,482 PHC Online visits grouped by 83 public primary healthcare centers. Multiple linear regression analysis was performed with PHC Online visits per 1,000 registered patients as the dependent variable and urbanicity (municipalities grouped by number of inhabitants), socioeconomic status (Care Need Index), and morbidity (Adjusted Clinical Groups) per primary healthcare center as independent variables...
April 15, 2024: International Journal for Equity in Health
https://read.qxmd.com/read/38619888/modes-of-action-and-potential-as-a-peptide-based-biofungicide-of-a-plant-defensin-mtdef4
#4
JOURNAL ARTICLE
Hui Li, Raviraj Kalunke, Meenakshi Tetorya, Kirk J Czymmek, Dilip M Shah
Due to rapidly emerging resistance to single-site fungicides in fungal pathogens of plants, there is a burgeoning need for safe and multisite fungicides. Plant antifungal peptides with multisite modes of action (MoA) have potential as bioinspired fungicides. Medicago truncatula defensin MtDef4 was previously reported to exhibit potent antifungal activity against fungal pathogens. Its MoA involves plasma membrane disruption and binding to intracellular targets. However, specific biochemical processes inhibited by this defensin and causing cell death have not been determined...
April 2024: Molecular Plant Pathology
https://read.qxmd.com/read/38612432/aflibercept-off-target-effects-in-diabetic-macular-edema-an-in-silico-modeling-approach
#5
JOURNAL ARTICLE
Morgane Blanot, Ricardo Pedro Casaroli-Marano, Jordi Mondéjar-Medrano, Thaïs Sallén, Esther Ramírez, Cristina Segú-Vergés, Laura Artigas
Intravitreal aflibercept injection (IAI) is a treatment for diabetic macular edema (DME), but its mechanism of action (MoA) has not been completely elucidated. Here, we aimed to explore IAI's MoA and its multi-target nature in DME pathophysiology with an in silico (computer simulation) disease model. We used the Therapeutic Performance Mapping System (Anaxomics Biotech property) to generate mathematical models based on the available scientific knowledge at the time of the study, describing the relationship between the modulation of vascular endothelial growth factor receptors (VEGFRs) by IAI and DME pathophysiological processes...
March 23, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611495/induction-of-monoterpenoid-oxindole-alkaloids-production-and-related-biosynthetic-gene-expression-in-response-to-signaling-molecules-in-hamelia-patens-plant-cultures
#6
JOURNAL ARTICLE
Ana Luisa López-Vázquez, Edgar Baldemar Sepúlveda-García, Elizabeth Rubio-Rodríguez, Teresa Ponce-Noyola, Gabriela Trejo-Tapia, Josefina Barrera-Cortés, Carlos M Cerda-García-Rojas, Ana C Ramos-Valdivia
Hamelia patens (Rubiaceae), known as firebush, is a source of bioactive monoterpenoid oxindole alkaloids (MOAs) derived from monoterpenoid indole alkaloids (MIAs). With the aim of understanding the regulation of the biosynthesis of these specialized metabolites, micropropagated plants were elicited with jasmonic acid (JA) and salicylic acid (SA). The MOA production and MIA biosynthetic-related gene expression were evaluated over time. The production of MOAs was increased compared to the control up to 2-fold (41...
March 27, 2024: Plants (Basel, Switzerland)
https://read.qxmd.com/read/38608696/new-and-emerging-treatments-for-metabolic-dysfunction-associated-steatohepatitis
#7
REVIEW
Monica A Tincopa, Quentin M Anstee, Rohit Loomba
Metabolic dysfunction-associated steatohepatitis (MASH) is a leading etiology of chronic liver disease worldwide, with increasing incidence and prevalence in the setting of the obesity epidemic. MASH is also a leading indication for liver transplantation, given its associated risk of progression to end-stage liver disease. A key challenge in managing MASH is the lack of approved pharmacotherapy. In its absence, lifestyle interventions with a focus on healthy nutrition and regular physical activity have been the cornerstone of therapy...
April 7, 2024: Cell Metabolism
https://read.qxmd.com/read/38585902/space-swift-phenotypic-analysis-of-cells-an-open-source-single-cell-analysis-of-cell-painting-data
#8
Fabio Stossi, Pankaj K Singh, Michela Marini, Kazem Safari, Adam T Szafran, Alejandra Rivera Tostado, Christopher D Candler, Maureen G Mancini, Elina A Mosa, Michael J Bolt, Demetrio Labate, Michael A Mancini
Phenotypic profiling by high throughput microscopy has become one of the leading tools for screening large sets of perturbations in cellular models. Of the numerous methods used over the years, the flexible and economical Cell Painting (CP) assay has been central in the field, allowing for large screening campaigns leading to a vast number of data-rich images. Currently, to analyze data of this scale, available open-source software ( i.e. , CellProfiler) requires computational resources that are not available to most laboratories worldwide...
March 26, 2024: bioRxiv
https://read.qxmd.com/read/38580097/exploring-a-mechanism-based-approach-for-the-identification-of-endocrine-disruptors-using-adverse-outcome-pathways-and-new-approach-methodologies-a-perfluorooctane-sulfonic-acid-case-study
#9
JOURNAL ARTICLE
Linus Wiklund, Marek Pípal, Jana Weiss, Anna Beronius
Endocrine disruptors (EDs) pose a serious threat to human health and the environment and require a comprehensive evaluation to be identified. The identification of EDs require a substantial amount of data, both in vitro and in vivo, due to the current scientific criteria in the EU. At the same time, the EU strives to reduce animal testing due to concerns regarding animal welfare and sensitivity of animal studies to adequately detect adverse effects relevant for human health. Perfluorooctane sulfonic acid (PFOS) is a persistent organic pollutant that is suspected to be an ED based on academic research, however it is not identified as such from a regulatory perspective...
April 3, 2024: Toxicology
https://read.qxmd.com/read/38579643/a-mini-review-of-the-anti-sars-cov-2-potency-of-amaryllidaceae-alkaloids
#10
JOURNAL ARTICLE
Ngoc-Thao-Hien Le, Kerrin Janssen, Johannes Kirchmair, Luc Pieters, Emmy Tuenter
BACKGROUND: Nature has perennially served as an infinite reservoir of diverse chemicals with numerous applications benefiting humankind. In recent years, due to the emerging COVID-19 pandemic, there has been a surge in studies on repurposing natural products as anti-SARS-CoV-2 agents, including plant-derived substances. Among all types of natural products, alkaloids remain one of the most important groups with various known medicinal values. The current investigation focuses on Amaryllidaceae alkaloids (AAs) since AAs have drawn significant scientific attention as anti-SARS-CoV-2 agents over the past few years...
March 29, 2024: Phytomedicine
https://read.qxmd.com/read/38578920/green-light-triggered-photocatalytic-anticancer-activity-of-terpyridine-based-ru-ii-photocatalysts
#11
JOURNAL ARTICLE
Arif Ali Mandal, Virendra Singh, Sukanta Saha, Silda Peters, Tumpa Sadhukhan, Rajesh Kushwaha, Ashish Kumar Yadav, Apurba Mandal, Aarti Upadhyay, Arpan Bera, Arnab Dutta, Biplob Koch, Samya Banerjee
The relentless increase in drug resistance of platinum-based chemotherapeutics has opened the scope for other new cancer therapies with novel mechanisms of action (MoA). Recently, photocatalytic cancer therapy, an intrusive catalytic treatment, is receiving significant interest due to its multitargeting cell death mechanism with high selectivity. Here, we report the synthesis and characterization of three photoresponsive Ru(II) complexes, viz., [Ru(ph-tpy)(bpy)Cl]PF6 ( Ru1 ), [Ru(ph-tpy)(phen)Cl]PF6 ( Ru2 ), and [Ru(ph-tpy)(aip)Cl]PF6 ( Ru3 ), where, ph-tpy = 4'-phenyl-2,2':6',2″-terpyridine, bpy = 2,2'-bipyridine, phen = 1,10-phenanthroline, and aip = 2-(anthracen-9-yl)-1 H -imidazo[4,5- f ][1,10] phenanthroline, showing photocatalytic anticancer activity...
April 5, 2024: Inorganic Chemistry
https://read.qxmd.com/read/38578824/a-platform-for-predicting-mechanism-of-action-based-on-bacterial-transcriptional-responses-identifies-an-unusual-dna-gyrase-inhibitor
#12
JOURNAL ARTICLE
Shawn French, Amelia Bing Ya Guo, Michael J Ellis, Julia P Deisinger, Jarrod W Johnson, Kenneth Rachwalski, Zoë A Piquette, Telmah Lluka, Miranda Zary, Sineli Gamage, Jakob Magolan, Eric D Brown
In the search for much-needed new antibacterial chemical matter, a myriad of compounds have been reported in academic and pharmaceutical screening endeavors. Only a small fraction of these, however, are characterized with respect to mechanism of action (MOA). Here, we describe a pipeline that categorizes transcriptional responses to antibiotics and provides hypotheses for MOA. 3D-printed imaging hardware PFIboxes) profiles responses of Escherichia coli promoter-GFP fusions to more than 100 antibiotics. Notably, metergoline, a semi-synthetic ergot alkaloid, mimics a DNA replication inhibitor...
April 4, 2024: Cell Reports
https://read.qxmd.com/read/38574385/comparison-of-transcriptomic-profiles-between-hfpo-da-and-prototypical-ppar%C3%AE-ppar%C3%AE-and-cytotoxic-agents-in-wild-type-and-ppar%C3%AE-knockout-mouse-hepatocytes
#13
JOURNAL ARTICLE
Melissa M Heintz, William D Klaren, Alexander W East, Laurie C Haws, Steven R McGreal, Rebecca R Campbell, Chad M Thompson
Recent in vitro transcriptomic analyses for the short-chain polyfluoroalkyl substance (PFAS), HFPO-DA (ammonium, 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate), support conclusions from in vivo data that HFPO-DA-mediated liver effects in mice are part of the early key events of the peroxisome proliferator-activated receptor alpha (PPARα) activator-induced rodent hepatocarcinogenesis mode of action (MOA). Transcriptomic responses in HFPO-DA-treated rodent hepatocytes have high concordance with those treated with a PPARα agonist and lack concordance with those treated with PPARγ agonists or cytotoxic agents...
April 4, 2024: Toxicological Sciences: An Official Journal of the Society of Toxicology
https://read.qxmd.com/read/38574381/comparison-of-transcriptomic-profiles-between-hfpo-da-and-prototypical-ppar%C3%AE-ppar%C3%AE-and-cytotoxic-agents-in-mouse-rat-and-pooled-human-hepatocytes
#14
JOURNAL ARTICLE
Melissa M Heintz, William D Klaren, Alexander W East, Laurie C Haws, Steven R McGreal, Rebecca R Campbell, Chad M Thompson
Like many per- or polyfluorinated alkyl substances (PFAS), toxicity studies with HFPO-DA (ammonium, 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate), a short-chain PFAS used in the manufacture of some types of fluorinated polymers, indicate that the liver is the primary target of toxicity in rodents following oral exposure. Although the current weight of evidence supports the PPARα mode of action (MOA) for liver effects in HFPO-DA-exposed mice, alternate MOAs have also been hypothesized including PPARγ or cytotoxicity...
April 4, 2024: Toxicological Sciences: An Official Journal of the Society of Toxicology
https://read.qxmd.com/read/38572496/an-assessment-of-open-fracture-management-in-hospitals-in-malawi-before-and-immediately-after-implementing-open-fracture-guidelines
#15
JOURNAL ARTICLE
Maureen Sabawo, Zahra Jaffry, Linda Chokotho, Alexander Thomas Schade
BACKGROUND: Open fractures, a common consequence of road traffic collisions, are associated with a high risk of complications. The introduction of standard guidelines has been shown to improve patient care and reduce the risk of complications in several countries. In September 2021, the Malawi Orthopaedic Association/Arbeitsgemeinschaft für Osteosynthesefragen Alliance (MOA/AOA) guidelines and standards for open fracture management were introduced in Malawi. This study aimed to assess the management of open fractures in hospitals in Malawi, before and after implementing a training course on the MOA/AOA open fracture guidelines...
2024: JB & JS Open Access
https://read.qxmd.com/read/38572114/super-resolution-imaging-for-in-situ-monitoring-sub-cellular-micro-dynamics-of-small-molecule-drug
#16
JOURNAL ARTICLE
Huimin Chen, Guiqian Fang, Youxiao Ren, Weiwei Zou, Kang Ying, Zhiwei Yang, Qixin Chen
Small molecule drugs play a pivotal role in the arsenal of anticancer pharmacological agents. Nonetheless, their small size poses a challenge when directly visualizing their localization, distribution, mechanism of action (MOA), and target engagement at the subcellular level in real time. We propose a strategy for developing triple-functioning drug beacons that seamlessly integrate therapeutically relevant bioactivity, precise subcellular localization, and direct visualization capabilities within a single molecular entity...
April 2024: Acta Pharmaceutica Sinica. B
https://read.qxmd.com/read/38565185/enhancing-the-small-scale-screenable-biological-space-beyond-known-chemogenomics-libraries-with-gray-chemical-matter%C3%A2-compounds-with-novel-mechanisms-from-high-throughput-screening-profiles
#17
JOURNAL ARTICLE
Jason R Thomas, Claude Shelton, Jason Murphy, Scott Brittain, Mark-Anthony Bray, Peter Aspesi, John Concannon, Frederick J King, Robert J Ihry, Daniel J Ho, Martin Henault, Andrea Hadjikyriacou, Marilisa Neri, Frederic D Sigoillot, Helen T Pham, Matthew Shum, Louise Barys, Michael D Jones, Eric J Martin, Anke Blechschmidt, Sébastien Rieffel, Thomas J Troxler, Felipa A Mapa, Jeremy L Jenkins, Rishi K Jain, Peter S Kutchukian, Markus Schirle, Steffen Renner
Phenotypic assays have become an established approach to drug discovery. Greater disease relevance is often achieved through cellular models with increased complexity and more detailed readouts, such as gene expression or advanced imaging. However, the intricate nature and cost of these assays impose limitations on their screening capacity, often restricting screens to well-characterized small compound sets such as chemogenomics libraries. Here, we outline a cheminformatics approach to identify a small set of compounds with likely novel mechanisms of action (MoAs), expanding the MoA search space for throughput limited phenotypic assays...
April 2, 2024: ACS Chemical Biology
https://read.qxmd.com/read/38561762/building-resilience-analysis-of-health-care-leaders-perspectives-on-the-covid-19-response-in-region-stockholm
#18
JOURNAL ARTICLE
Carl Savage, Leonard Tragl, Moa Malmqvist Castillo, Louisa Azizi, Henna Hasson, Carl Johan Sundberg, Pamela Mazzocato
BACKGROUND: The Covid-19 pandemic has tested health care organizations worldwide. Responses have demonstrated great variation and Sweden has been an outlier in terms of both strategy and how it was enacted, making it an interesting case for further study. The aim of this study was to explore how health care leaders experienced the challenges and responses that emerged during the initial wave of the Covid-19 pandemic, and to analyze these experiences through an organizational resilience lens...
April 2, 2024: BMC Health Services Research
https://read.qxmd.com/read/38548953/development-and-validation-of-a-cell-based-binding-neutralizing-antibody-assay-for-an-antibody-drug-conjugate
#19
JOURNAL ARTICLE
Weifeng Xu, Nazneen Bano, Olguitza Guzman-Valdes, Jessica Amberman, Elisha Bandlamudi, Pooja Khanna, Rebecca Carmean, Roy Helmy
The utilization of antibody-drug conjugates (ADCs) has gained considerable attention in the field of targeted cancer therapy due to their ability to synergistically combine the specificity of monoclonal antibodies (mAbs) and the potency of small molecular drugs. However, the immunogenic nature of the antibody component within ADCs warrants the need for robust immunogenicity testing, including a neutralizing antibody (NAb) assay. Since the mechanism of action (MOA) of the ADC is to first bind to the target cells and then release the payload intracellularly to kill the cells, the most relevant NAb assay format would be a cell-based killing assay...
March 28, 2024: AAPS Journal
https://read.qxmd.com/read/38547338/humanized-mice-for-studying-hiv-latency-and-potentially-its-eradication
#20
JOURNAL ARTICLE
Moa F Hasler, Roberto F Speck, Nicole P Kadzioch
PURPOSE OF THE REVIEW: The quest for an HIV cure faces a formidable challenge: the persistent presence of latent viral infections within the cells and tissues of infected individuals. This review provides a thorough examination of discussions surrounding HIV latency, the use of humanized mouse models, and strategies aimed at eliminating the latent HIV reservoir. It explores the hurdles and advancements in understanding HIV pathogenesis, mainly focusing on establishing latent reservoirs in CD4+ T cells and macrophages...
March 28, 2024: Current Opinion in HIV and AIDS
keyword
keyword
83137
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.